NFKB1 and colorectal cancer: The outcomes depicted that adenocarcinoma was alleviated alongside proinflammatory markers, that is, interleukin‐1β, cyclooxygenase‐2, NF‐κB, and inducible nitric oxide synthase, thereby attenuating colorectal cancer.